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ABSTRACT
Transferases of the Fem family catalyse peptide-
bond formation by using aminoacyl-tRNAs and pep-
tidoglycan precursors as donor and acceptor
substrates, respectively. The specificity of Fem
transferases is essential since mis-incorporated
amino acids could act as chain terminators thereby
preventing formation of a functional stress-bearing
peptidoglycan network. Here we have developed
chemical acylation of RNA helices with natural and
non-proteinogenic amino acids to gain insight into
the specificity of the model transferase FemXWv.
Combining modifications in the RNA and aminoacyl
moieties of the donor substrate revealed that unfa-
vourable interactions of FemXWv with the acceptor
arm of tRNA
Gly and with L-Ser or larger residues
quantitatively accounts for the preferential transfer
of L-Ala observed with complete aminoacyl-tRNAs.
The main FemXWv identity determinant was identi-
fied as the penultimate base pair (G
2-C
71) of the
acceptor arm instead of G
3 U
70 for the alanyl-tRNA
synthetase. FemXWv tolerated a configuration inver-
sion of the Ca of L-Ala but not the introduction of a
second methyl on this atom. These results indicate
that aminoacyl-tRNA recognition by FemXWv is dis-
tinct from other components of the translation
machinery and relies on the exclusion of bulky
amino acids and of the sequence of tRNA
Gly from
the active site.
INTRODUCTION
Peptidoglycan is a giant macromolecule, in the order of
3 10
9 to 30 10
9 Da, that completely surrounds the
cytoplasmic membrane and thereby provides a mechanical
protection against the turgor pressure of the cytoplasm.
Since the osmoprotective function is required in continuity
throughout the cell cycle, peptidoglycan metabolism is
intimately involved in cell division (1). Peptidoglycan
also provides a scaﬀold to anchor various surface poly-
mers that interact with host cells and the immune system
(2,3). These multiple functions are fulﬁlled by polymeriza-
tion of a relatively simple subunit, a disaccharide peptide,
that was recently shown to display little conformational
heterogeneity by solid-state nuclear magnetic resonance of
the intact polymer (4). Formation of the peptidoglycan
network involves two main enzyme activities, glycosyl-
transferase and D,D-transpeptidase, that are often com-
bined in multifunctional proteins belonging to the
penicillin-binding protein family (PBP). The glycosyltrans-
ferases polymerize glycan strands made of alternating
b,1!4-linked N-acetyl-glucosaminyl (GlcNAc) and
N-acetyl-muramyl (MurNAc) residues. The 3D nature of
the peptidoglycan network is provided by the cross-linking
of short stem peptides born by MurNAc residues from
adjacent glycan strands (5).
Formation of the peptidoglycan network (Figure 1)
involves diﬀerent types of peptide and amide bond synthe-
sizing enzymes. The Mur synthetases form cytoplasmic
UDP-MurNAc-pentapeptide by sequential addition of
amino acids with alternating L and D conﬁgurations
except for the terminal D-Ala-D-Ala dipeptide (6).
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carboxyl of the acyl donor by formation of an acyl phos-
phate. The precursors of many Gram-positive bacteria
contain an additional side chain linked to the third
amino acid of the stem pentapeptide. The side chain com-
prises from one to seven amino acids belonging both to
the L and D series (7). Glycine and L-amino acids are acti-
vated as aminoacyl-tRNAs by the aminoacyl-tRNA
synthetases involved in protein synthesis and are trans-
ferred to the peptidoglycan precursors by Fem
transferases that belong to the GCN5-related N-acetyl-
transferase (GNAT) protein superfamily (8,9). The side
chain carboxyl of D-Asp and D-Glu is activated as an
acyl-phosphate and subsequently ligated to the precursors
by members of the ATP-Grasp protein superfamily (10).
The ﬁnal cross-linking step is performed by active-site
serine peptidases that cleave the D-Ala
4-D-Ala
5 peptide
bond of an acyl donor (transpeptidase of the D,D
speciﬁcity) and link the carbonyl of D-Ala
4 to the amine
located at the extremity of the side chain of an acyl accep-
tor (11). In enterococci resistant to b-lactams and in
Mycobacterium tuberculosis, these members of the PBP
family can be replaced by active-site cysteine peptidases
that cleave the L-Lys
3-D-Ala
4 peptide bond of an
acyl donor (transpeptidase of the L,D speciﬁcity) and
link the carbonyl of L-Lys
3 to the amine of the acyl accep-
tor (12,13).
The speciﬁcity of peptide and amide forming enzymes is
essential for bacteria since mis-incorporated amino acids
can act as chain terminators (6,14) and block the ﬁnal
cross-linking step of peptidoglycan polymerization
(15,16). The sequence of the peptide network has a critical
impact on the activity of amidases and peptidases that
fulﬁl a wide variety of physiological functions including
peptidoglycan recycling, separation of daughter cells after
division and partial hydrolysis of the peptidoglycan net-
work thought to be required both for insertion of novel
subunits into the pre-existing material and for crossing of
macromolecular structures such as pili and ﬂagella
through the peptidoglycan layer (17). Finally, the
sequence of the peptide network determines the suscepti-
bility of the peptidoglycan to hydrolases produced by
competing bacteria (18).
Fem transferases are considered as attractive targets for
the development of novel antibiotics active against multi-
resistant bacteria (14). These enzymes have a unique
catalytic mechanism (19,20) and are essential either for
viability (21) or for expression of b-lactam resistance
mediated by low-aﬃnity PBPs (22–24). Characterized
members of this family include FemABX from
Staphylococcus aureus that sequentially add one (FemX)
or two (FemA and FemB) glycines (25) and homologues
from Streptococcus pneumoniae (MurMN) (22,26)
and Enterococcus faecalis (BppA1A2) (27,28) for incorpo-
ration of single residues into L-Ala (or L-Ser)-L-Ala side
chains. In addition, FemXWv from Weissella viridescens
has been widely used as a model transferase since the
UDP-MurNAc-pentapeptide substrate of this enzyme
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Figure 1. Peptidoglycan synthesis pathway in W. viridescens. The FemXWv transferase adds the ﬁrst residue of the L-Ala-L-Ser-L-Ala side chain onto
the nucleotide precursor UDP-MurNAc-pentadepsipeptide. The Ala-tRNA
Ala substrate of FemXWv is produced by the alanyl-tRNA-synthetase
(AlaRS). Additional unknown Fem transferases add the second (L-Ser) and third (L-Ala) residues of the side chain onto the precursors linked to the
undecaprenyl lipid carrier (30). Black box, undecaprenyl; D-Lac, D-lactate; lipid II, undecaprenyl-diphospho-MurNAc(pentadepsipeptide)-GlcNAc.
D,D-transpeptidases belonging to the penicillin-binding protein (PBP) family catalyse formation of a peptide bound between the carbonyl of D-Ala
4 of
an acyl donor stem and the amine at the side chain extremity of an acceptor stem.
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ates used by other members of the family (20,27). FemXWv
catalysis proceeds by an ordered bi-bi mechanism with
sequential ﬁxation of the UDP-MurNAc-pentapeptide
and Ala-tRNA
Ala substrates and sequential release
of the tRNA
Ala and UDP-MurNAc-hexapeptide products
(19). Structure-based site-directed mutagenesis of the
UDP-MurNAc-pentapeptide-binding cavity of FemXWv
revealed that a complex hydrogen bond network
connects two residues of the enzyme (Lys
36 and Arg
211)
with two regions of UDP-MurNAc-pentapeptide (both
phosphate groups and both D-Ala residues) and constrains
the substrate in a bent conformation essential for the ami-
noacyl transferase activity (8,29). Analysis of the interac-
tion of FemXWv with the second substrate (Ala-tRNA
Ala)
showed that the acceptor stem of tRNA
Ala is suﬃcient for
aminoacyl transfer (30). Saturation mutagenesis of this
region of the substrate and modelling of the acceptor
stem in the FemXWv catalytic cavity suggested that
the enzyme only interacts with the two distal base pairs
(G
2-C
71 and G
1-C
72) and the single-stranded 30-end
(
73ACCA
76) (30). We have analysed the speciﬁcity of
FemXWv in the aminoacyl transfer reaction by systemati-
cally exploring the impact of modiﬁcations in the amino-
acyl residue and RNA sequence on the catalytic eﬃciency
of FemXWv.
MATERIALS AND METHODS
Enzyme purification
FemXWv (29), alanyl-tRNA synthetase (AlaRS) (27), T4
RNA ligase (30) and T7 RNA polymerase (30) were pur-
iﬁed according to previously published procedures.
Substrates
Full-length tRNA
Ala (50-GGGGCCUUAGCUCAGCUG
GGAGAGCGCCUGCUUUGCACG CAGGAGGUCA
GCGGUUCGAUCCCGCUAGGCUCCACCA-30) cor-
responds to the three identical sequences annotated as
tRNA
Ala in the genome sequence of E. faecalis strain
V583 (http://www.tigr.org/). This 76-nucleotide RNA
was obtained by in vitro transcription using T7 RNA poly-
merase (30). The choice of the E. faecalis rather than a
W. viridescens tRNA
Ala sequence was dictated by the fact
that the sequence of the genome of the latter bacteria is
unknown.
The peptidoglycan precursor UDP-MurNAc-L-Ala
1-
D-iGlu
2-L-Lys
3-D-Ala
4-D-Ala
5 (UDP-MurNAc-penta-
peptide) was synthesized as previously described (31).
Labelled UDP-MurNAc-L-[
14C]Ala
1-D-iGlu
2-L-Lys
3-D-
Ala
4-D-Ala
5 was prepared by sequential addition
of L-[
14C]Ala (6.3 GBq.mmol
 1; Perkin Elmer), D-Glu,
L-Lys and D-Ala-D-Ala by the puriﬁed MurC, D, E, F
synthetases (32).
Reagents and materials for organic synthesis
Solvents were dried using standard methods and distilled
before use. Unless otherwise speciﬁed, materials were pur-
chased from commercial suppliers and used without
further puriﬁcation. TLC: precoated silica gel thin layer
sheets 60 F254 (Merck). Flash chromatography: silica gel
60A ˚ , 180–240 mesh from Merck.
1H (250.13MHz),
13C
(62.90MHz) spectra were recorded on Bru ¨ ker ARX 250
spectrometer in CDCl3. Chemicals shifts ( ) are expressed
in ppm relative to residual CDCl3 (  7.26) for
1H, CDCl3
(  77.16) for
13C as internal references. Signals were attrib-
uted based on COSY and DEPT 135 (
13C). High resolu-
tion mass spectroscopy (HRMS) spectra were carried out
on a LTQ Orbitrap mass spectrometer (Thermo Fisher
Scientiﬁc Inc.) in the positive or negative electrospray ion-
ization modes (ESI) at the Mass Spectrometry Centre
of the University Pierre & Marie Curie (Paris). High-
performance liquid chromatography (HPLC) was per-
formed with reverse phase C-18 columns (analytic
column: 250 4.6mm, HYPERSIL-100 C18; semipre-
parative column: 250 21.2mm, HYPERSIL HS C18;
Thermoelectron Corporation). Compounds were eluted
at ﬂow rates of 1 and 17ml.min
 1 (for the analytic and
semipreparative columns, respectively) with a linear gra-
dient of CH3CN (0–33% in 45min) in 50mM aqueous
NH4OAc (pH 4.5).
Synthesis of [N-(4-pentenoyl)-aminoacyl]-pdCpAs
(compounds 2a-d)
The dinucleotides acylated by protected Gly, L-Ala, D-Ala
and 2-aminobutyrate (Abu) (compounds 2a–d in
Figure 2A) were synthesized according to a previously
described method (33,34). A solution of freshly distilled
DMF (100ml) containing 10mg of pdCpA tetrabutyl-
ammonium salt (7.35mmol) was added to 39.7mmol of
N-(4-pentenoyl)-amino-acid cyanomethyl esters (1a–d).
The reaction mixtures were stirred at room temperature
and monitored by rp-HPLC. Puriﬁcation on the semipre-
parative C18 reversed phase column led to compounds
2a–d (retention times: 2a, 13.8min; 2b, 14.7min; 2c,
14.9min; 2d, 16.3min) that were recovered as colourless
solids after lyophilization and analysed by ESI-HRMS.
2a: 44% yield (2.5mg); observed and calculated m/z of
774.1655 and 774.1650 for the [M – H]
  ion, respectively;
2b: 48% yield (2.8mg); m/z 790.1959 [M+H]
+ (calculated
790.1963); 2c: 52% yield (3.0mg); m/z 788.1785 [M H]
 
(calculated 788.1806); 2d: 60% yield (3.6mg); m/z
802.1959 [M H]
– (calculated 802.1963).
Synthesis of N-(4-pentenoyl)-L-serine methyl ester
(compound 4)
NaHCO3 (135mg; 1.61mmol) was added to an aqueous
solution (4ml) of L-serine methylester hydrochloride 3
(250mg; 1.61mmol) (Figure 2B). A solution of
4-pentenoic acid succinimide ester (35) (177mg in 4ml
of dioxane) was added under stirring at room tempera-
ture. After overnight stirring at room temperature, the
reaction mixture was diluted with 8ml of EtOAc and
8ml of 1M NaHSO4, and then extracted with EtOAc.
The combined organic extracts were dried over Na2SO4
and concentrated under diminished pressure. The crude
product was puriﬁed by ﬂash chromatography on a
silica gel column. Elution with 9:1 CH2Cl2/MeOH gave
4 as a colourless oil: 95% yield (307mg);
1H NMR
Nucleic Acids Research,2009, Vol.37, No. 5 1591(250MHz, CDCl3)   7.05 (br d, J=7.9, 1H), 5.72 (dd,
J=10.1, 17.0, 1H), 5.05 4.82 (m, 2H), 4.60–4.42 (m,
1H), 3.80 (ddd, J=3.6, 11.3, 34.1, 2H), 3.65 (s, 3H),
2.28 (m, 4H).
13C NMR (63MHz, CDCl3)   173.6,
171.0, 136.6, 115.5, 62.5, 54.4, 52.5, 35.1, 29.3ppm.
N-(4-pentenoyl)-O-tert-butyldimethylsilyl-L-serine methyl
ester (compound 5)
Compound 4 (286mg; 1.42mmol) was dissolved in 5ml of
anhydrous DMF. After sequential addition of TBSCl
(321mg; 2.13mmol) and imidazole (160mg; 2.34mmol),
the reaction mixture was stirred under argon overnight at
room temperature. The solution was diluted with 50ml of
brine and extracted with EtOAc. The combined organic
phase was washed with water, dried over Na2SO4 and
concentrated under diminished pressure. Puriﬁcation by
ﬂash chromatography on a silica gel column (95:5
CH2Cl2/MeOH) gave 5 as a colourless oil: 88% yield
(395mg);
1H NMR (250MHz, CDCl3)   6.35 (br d,
J=7.9, 1H), 5.92–5.67 (m, 1H), 5.12–4.90 (m, 2H),
4.70–4.57 (m, 1H), 3.88 (ddd, J=2.9, 10.1, 60.3, 2H),
3.69 (s, 3H), 2.45–2.24 (m, 4H), 0.81 (s, 9H), –0.02
(s, 3H), –0.03 (s, 3H).
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Figure 2. Semi-synthesis of Ala-tRNA
Ala analogues. (A) Organic synthesis of dinucleotides acylated by Gly, L-Ala, D-Ala and Abu protected with a
pentenoyl group. pdCpA, (50)phospho(20)deoxycytidine-(50)phosphoadenine. (B) Organic synthesis of pdCpA acylated by L-Ser protected with a
pentenoyl group. (C) Ligation of acylated dinucleotides to RNA helix
Ala. The product of the reaction catalysed by the T4 RNA ligase was
deprotected with iodine.
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N-(4-pentenoyl)-O-tert-butyldimethylsilyl-L-serine
cyanomethyl ester (compound 6)
LiOH (139mg; 3.31mmol) was added to a suspension
containing 348mg (1.10mmol) of 5 in 4ml of 1:1 THF/
water. The reaction mixture was stirred at room temper-
ature for 1h 30min, diluted with 40ml of EtOAc, washed
with 20ml of 1M NaHSO4, dried over Na2SO4 and con-
centrated under diminished pressure. The crude residue
was dissolved in 2.4ml of anhydrous CH3CN and chlor-
oacetonitrile (349ml; 5.5mmol) and triethylamine (766ml;
5.5mmol) were sequentially added. The reaction mixture
was stirred at room temperature overnight, diluted with
40ml of EtOAc, washed with 20ml of 1N NaHSO4, dried
over Na2SO4 and concentrated under diminished pressure.
Puriﬁcation by ﬂash chromatography on a silica gel
column (4:6 cycohexane/EtOAc) gave 6 as a colourless
oil: 65% yield (243mg);
1H NMR (250MHz, CDCl3)  
6.87 (br d, J=8.3, 1H), 6.47 6.26 (m, 1H), 5.69 5.50
(m, 2H), 5.42 5.20 (m, 3H), 4.47 (ddd, J=2.9, 10.2,
68.1, 2H), 3.00 2.85 (m, 4H), 1.39 (s, 9H), 0.57 (s, 6H).
13C NMR (63MHz, CDCl3)   172.3, 169.3, 136.7,
115.9,113.9, 63.3, 54.0, 49.1, 35.4, 29.3, 25.7, 18.2,
 5.6ppm.
N-(4-pentenoyl)-(S)- seryl-pdCpA(compound 8)
A solution of freshly distilled DMF (200ml) containing
20mg of pdCpA tetrabutylammonium salt (14.7mmol)
was added to N-(4-pentenoyl)-O-tert-butyldimethylsilyl-
L-serine cyanomethyl ester 6 (27mg; 79mmol). The
reaction mixture was stirred at room temperature
and monitored by rp-HPLC. N-(4-pentenoyl)-O-
tert-butyldimethylsilyl-(S)-seryl-pdCpA (compound 7)
was puriﬁed by preparative rp-HPLC (retention time
27.9min) and recovered by lyophilization as a white
solid: 36% yield (5.0mg). Final deprotection was per-
formed by treating protected compound 7 (5mg,
5.15mmol) with 680ml of 3:1:1 AcOH/THF/H2O (36) for
24h at room temperature under stirring. Compound 8 was
puriﬁed by rp-HPLC (retention time 15.9min) and recov-
ered as a colourless solid after lyophilization with a yield
of 72% (3.2mg). HRMS-ESI analysis revealed an m/z of
804.1756 [M – H]
– that matched the calculated value of
804.1755.
Synthesis ofthe aminoacyl-tRNA analoguescontaining an
oxadiazole ring
Synthesis of the modiﬁed nucleotide containing a
3-(S)-1-aminoethyl-1,2,4-oxadiazole ring as a mime of
the ester bond at the 30-end of the RNA helices was per-
formed as previously described (37).
Ligation ofmodified dinucleotides to RNA helices
Modiﬁed dinucleotides [pdCpA-aminoacyl-pentenoyl
and pdCpA substituted by a 3-(S)-1-aminoethyl-
1,2,4-oxadiazole ring] were ligated to RNA helices with
puriﬁed T4 RNA ligase (37) (Figure 2C). The RNA
helices, which did not contain the terminal pCpA, were
synthesized by the phosphoramidite method and puriﬁed
by polyacrylamide gel electrophoresis (Eurogentec). The
inhibitors containing the oxadiazole ring were puriﬁed by
anion exchange chromatography (DEAE column,
DNAPac-100, Dionex) with a linear gradient of ammo-
nium acetate pH 8.0 (25–2500mM) containing 0.5% acet-
onitrile. Fractions containing the ligation product were
identiﬁed by denaturing polyacrylamide gel electrophor-
esis (37), lyophilized, resuspended in RNAse free water
(Sigma) and stored at –208C. The concentration of the
inhibitors was determined spectrophotometrically
(e=2.26 10
5M
 1cm
 1 at 260nm). The substrates con-
taining the aminoacyl-pentenoyl groups were puriﬁed by
ethanol precipitation (34). The pentenoyl group was
removed with iodine prior to enzyme assay (35).
Determination of therelative activity of FemXWvwith
aminoacylated RNA helices
FemXWv activity was determined in 50mM ammonium
acetate (pH 6.5) containing 12.5mM mgCl2, 0.1mg/ml
bovine serum albumin, enzyme (0.75 nM to 10mM),
UDP-MurNAc-[
14C]pentapeptide (78mM) and acylated
helices (3 –10mM). The reaction was allowed to proceed
for 30min at 378C and an incubation of 10min at 968C
was used to stop the reaction. UDP-MurNAc-
[
14C]hexapeptides produced by FemXWv were determined
by rp-HPLC coupled to a radioﬂow detector using a C18
column (Nucleosil; 25cm, 3mM; Machery–Nagel). Elution
was performed at a ﬂow rate of 0.5ml/min with a linear
gradient of acetonitrile (0–4%) in 50mM ammonium ace-
tate pH 5.0, which was applied between 15 and 55min.
Reproducibility was assessed with two to three indepen-
dent preparations of aminoacyltated RNA helices and
standard deviations were calculated by linear regression
using a set of data generated with the same batch of
substrate.
Inhibition of FemXWvby analoguesof Ala-tRNA
Ala
The assay contained Tris–HCl (50mM, pH 7.5), alanyl-
tRNA synthetase of E. faecalis (800 nM), ATP (7.5mM),
MgCl2 (12.5mM), L-[
14C]Ala (50mM, 3700Bq/nmol;
ICN, Orsay, France), FemXWv (2nM), UDP-MurNAc-
pentapeptide (5mM), tRNA
Ala (0.4mM) and inhibitors
(0–200mM). The reaction was performed at 378C for
10min with a preincubation of 2min in the absence of
FemXWv for synthesis of Ala-tRNA
Ala by the auxiliary
system. The reaction was stopped at 968C for 10min and
analysed by descending paper chromatography (Whatman
4mm, Elancourt) with isobutyric acid-ammonia, 1M
(5:3 per vol). Radioactive spots were identiﬁed by auto-
radiography, cut out and counted by liquid scintillation.
RESULTS
Synthesis of aminoacyl-tRNA analoguesand design of a
FemXWv assayforthe resulting substrates
Acylated RNA helices were obtained by semi-synthesis
(Figure 2). The main steps involved organic synthesis of
Nucleic Acids Research,2009, Vol.37, No. 5 1593dinucleotides acylated by protected amino acids
(Figure 2A and B). The acylated dinucleotides were ligated
with T4 RNA ligase to 22-nt RNA helices that mimic the
acceptor arm of tRNAs (Figure 2C). The extent of the
transfer of amino-acid residues from acylated helices to
UDP-MurNAc-[
14C]pentapeptide (reaction depicted in
Figure 3A) was determined by rp-HPLC coupled to a
radioﬂow detector (Figure 3B). Since the ester link con-
necting the amino-acid residues to the RNA helices was
unstable, the deprotection step (Figure 2C) was performed
immediately prior to the assay and the initial concentra-
tion of the aminoacylated helices was determined in each
experiment. For this purpose, high concentrations of
FemXWv and an excess of UDP-MurNAc-pentapeptide
were used to obtain full transfer of the residue
(Figure 3C). The concentration of UDP-MurNAc-
[
14C]hexapeptide obtained after full transfer was used to
evaluate the initial concentrations of the acylated RNA
helices that varied between experiments according to the
yield (30–80%) of the ligation and deprotection steps. For
each substrate, a range of FemXWv concentrations was
identiﬁed in which formation of the product was propor-
tional to the time of reaction (data not shown) and to the
enzyme concentration (Figure 3D). The slopes of the
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Figure 3. Speciﬁcity of FemXWv for the aminoacyl residue. (A) The relative eﬃciency of FemXWv was estimated for the transfer of L-Ala, L-Ser and
Gly from acylated RNA helix
Ala to UDP-MurNAc-[
14C]pentapeptide. (B) The radiolabelled substrate and product of the reaction catalysed by
FemXWv were determined by rp-HPLC coupled to a radioﬂow detector. The superimposed chromatograms provide examples of the separation of the
UDP-MurNAc-[
14C]hexapeptide product containing L-Ala (a), L-Ser (b) or Gly (c) from the UDP-MurNAc-[
14C]pentapeptide substrate (d) common
to the three reactions. CTS, counts per s. (C) The initial concentration of acylated RNA helix
Ala in each reaction was estimated following complete
transfer of the residue at high concentrations of FemXWv (after completion of the aminoacyl transfer reaction, the concentration of UDP-MurNAc-
[
14C]hexapeptide was equal to the initial concentration of the Ala-helix
Ala). (D) At lower concentrations of FemXWv, the extent of the transfer was
proportional to the concentration of FemXWv.( E) The slopes were used to estimate the relative eﬃciency of the enzyme for the diﬀerent acylated
helices.
1594 Nucleic Acids Research, 2009, Vol. 37,No. 5linear portion of the curves were used to determine the
relative eﬃciency of the transfer reaction with the diﬀerent
acylated donor substrates (Figure 3E).
Relative activity ofFemXWvfor thetransfer of L-Ala, L-Ser
and Gly from helix
Alato UDP-MurNAc-pentapeptide
Comparison of the eﬃciency of transfer of L-Ala and L-Ser
from helix
Ala to UDP-MurNAc-[
14C]pentapeptide indi-
cated that FemXWv eﬃciently discriminated between the
methyl and hydroxymethyl side chains of the residues
(7.0% relative eﬃciency). A similar relative eﬃciency
(6.0%) was previously reported for the complete amino-
acyl-tRNAs (Ala-tRNA
Ala versus Ser-tRNA
Ser) (30).
Thus, exclusion of Ser from the active site of FemXWv
was suﬃcient to account for enzyme speciﬁcity since the
Ala-helix
Ala and Ser-helix
Ala only diﬀered by the amino-
acyl residue. In contrast, Gly-helix
Ala was eﬃciently used
by FemXWv (33% relative eﬃciency) whereas Gly-
tRNA
Gly was a poor substrate (2.6%). Thus, discrimina-
tion between Ala-tRNA
Ala and Gly-tRNA
Gly involved
diﬀerent interactions between the FemXWv and the
RNA moiety of the substrate.
Transfer of L-Ala from helices mimicking tRNA
Ala,tRNA
Ser
and tRNA
Gly
The sequence of tRNA
Ala, tRNA
Ser and tRNA
Gly diﬀers
at four positions in the distal portion of the acceptor arm
(boxed in Figure 4A). Nucleotide substitutions were
introduced in these positions of helix
Ala to generate helices
that mimic the acceptor arm of tRNA
Ser and tRNA
Gly
(designated helix
Ser and helix
Gly, respectively).
Introduction of the combination of the G
3!A and
A
73!G substitutions, required to generate helix
Ser from
helix
Ala, had a moderate impact on FemXWv activity (rela-
tive eﬃciency of 31%; Figure 4B and C). Thus, modiﬁca-
tion of the acceptor arm of helix
Ala conﬁrmed that
FemXWv discriminates between Ala-tRNA
Ala and Ser-
tRNA
Ser mainly at the level of the aminoacyl residue.
The opposite result was observed for Ala-helix
Gly.I n
this case, the relative eﬃciency of transfer of L-Ala from
helix
Gly and helix
Ala (2.9%) was similar to the relative
eﬃciency observed for the complete aminoacyl-tRNAs
(2.6% for comparison of Ala-tRNA
Ala and Gly-
tRNA
Gly) (30). Together, these results indicate that the
speciﬁcity of FemXWv depends both on the aminoacyl res-
idue (discrimination between L-Ser and L-Ala) and the
nucleotide sequence of the RNA moiety of the substrate
(discrimination between tRNA
Ala and tRNA
Gly).
Inhibition of FemXWvby stableanalogues of
aminoacyl-tRNAs
To gain insight into the interaction of FemXWv with
helix
Ala, helix
Ser and helix
Gly, stable analogues of the ami-
noacylated helices were synthesized by introducing an
oxadiaxole-containing substituant at the 30-end of the hel-
ices (Figure 5A). The oxadiazole ring was previously
shown to act as an isoster of the ester link connecting
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Figure 4. Speciﬁcity of FemXWv for the sequence of the acceptor arm of tRNA
Ala, tRNA
Ser and tRNA
Gly.( A) RNA sequence of the helices.
Nucleotide substitutions introduced into helix
Ala in order to obtain helix
Ser and helix
Gly are boxed. The sequence of the distal portion of the helix
Ser
and helix
Gly (base pairs 1–72, 2–71, 3–70 and unpaired bases 73–76) were design according to the sequence of the acceptor arm of tRNA
Ser and
tRNA
Gly.( B and C) The relative eﬃciency of FemXWv was estimated for the transfer of L-Ala from the RNA helices to UDP-MurNAc-
[
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Nucleic Acids Research,2009, Vol.37, No. 5 1595the amino-acid residue to the tRNA (37). The oxadiazole
ring was substituted by a 2-amino-ethyl group mimicking
L-Ala (oxa). The IC50s for the oxa-helix
Ser and oxa-
helix
Gly were 11- and 48-fold higher than the IC50 of the
oxa-helix
Ala, respectively (Figure 5B). These results show
that diﬀerences in the sequence of the acceptor arm of
tRNA
Ala, tRNA
Ser and tRNA
Gly aﬀect binding of
FemXWv to the RNA substrate. The largest eﬀect was
observed between helix
Ala and helix
Gly underscoring
again the key role of diﬀerences in the mode of recognition
of the acceptor arm of the tRNA
Ala and tRNA
Gly for the
speciﬁcity of FemXWv.
FemXWv identity determinants inthe acceptorarm
oftRNA
Ala
Substitutions were introduced in the distal portion of the
acceptor arm of Ala-helix
Ala to evaluate the role of speciﬁc
bases on FemXWv activity (Figure 6). The discriminator
base (position 73) was not a key element for FemXWv
speciﬁcity since a residual activity of 62% was observed
for the modiﬁed Ala-helix
Ala containing the A
73!G sub-
stitution. The C
72!G substitution in the ﬁrst base pair of
the acceptor stem led to a 100-fold decrease in the catalytic
activity of FemXWv. The impact of the substitution
involved at least in part the destabilization of the RNA
helix since introduction of a second substitution G
1!C,
which restored a Watson–Crick base pair, increased the
residual activity 6.5-fold. In contrast, a similar analysis of
the 2-71 base pair led to the opposite conclusion since the
replacement of G
2-C
71 by G
2 G
71 and C
2-G
71 led to resid-
ual activity of 38 and 1.8%, respectively. This result indi-
cates that the C
2-G
71 base pair of tRNA
Gly acts as a major
anti-determinant to prevent incorporation of Gly into
peptidoglycan precursors by FemXWv. Conversely, the
moderate impact of the G
3!A (45% residual activity)
and A
73!G (62%) substitutions are in agreement with
the comparison of misacylated tRNAs (Figure 4) that
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1596 Nucleic Acids Research, 2009, Vol. 37,No. 5led to the conclusion that Ser-tRNA
Ser is mainly excluded
from the FemXWv active site due to unfavourable interac-
tion with the aminoacyl residue.
Stereospecificity of FemXWv
The helix
Ala substituted by D-Ala instead of L-Ala was
used as a substrate by FemXWv albeit with a 110-fold
reduced catalytic eﬃciency (Figure 7). Thus, the conﬁgu-
ration of the Ca of the L-alanyl residue was preferred but
not essential for FemXWv activity. 2-Amino-isobutyrate,
which combines two methyl groups at this position, was
not used as a substrate.
DISCUSSION
The main function of aminoacyl-tRNAs is the inter-
pretation of the genetic code by providing the interface
between nucleic acid triplets in mRNA and the corre-
sponding amino acids in proteins. Aminoacyl-tRNAs
also participate in the synthesis of proteinogenic amino
acids such as glutamine and asparagine by amidation of
Glu-tRNA
Gln and Asp-tRNA
Asn or selenocysteine by
conversion of Ser-tRNA
Sec into Sec-tRNA
Sec (38,39).
The misacylated tRNA intermediates of the tRNA-
dependent amino-acid biosynthesis pathways are not
recognized by EF-Tu or by the corresponding speciﬁc
elongation factors (38,39). The ﬁdelity of translation is
preserved by this mechanism and by the assembly of the
participating biosynthetic enzymes in stable ribonucleo-
protein complexes that channel the misacylated tRNAs
through the diﬀerent catalytic steps and prevent their
interaction with the translation machinery (40).
Independently from their role as translation substrates,
certain aminoacyl-tRNAs act as aminoacyl donors in sev-
eral biosynthesis pathways (41) including the assembly of
the side chain of peptidoglycan precursors (42) (Figure 1).
In addition, Glu-tRNA
Glu participates in the synthesis of
porphyrins (43), Lys-tRNA
Lys and Ala-tRNA
Ala are used
for aminoacylation of phosphatidylglycerol (44) and Phe-
tRNA
Phe and Leu-tRNA
Leu act as aminoacyl donors for
labelling the N-terminus of proteins targeted for degrada-
tion by the proteasome-like protease ClpAP (45). The ami-
noacyl-tRNA substrates of all these reactions are correctly
acylated and have therefore the dual capacity to partici-
pate in two pathways. Partial uncoupling mediated by
helixAla
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Nucleic Acids Research,2009, Vol.37, No. 5 1597dedicated tRNAs have been reported in rare instances. In
Acidithiobacillus ferrooxidans for example, one of the three
Glu-tRNA
Glu that act as translation substrates does not
participate in porphyrin synthesis probably ensuring an
adequate supply of Glu-tRNA
Glu upon high heme
demand (46). In Staphylococcus epidermidis, an adequate
supply of Gly-tRNA
Gly to the synthesis of the side chain
of peptidoglycan precursors could be provided by two
closely related tRNA
Gly that do not participate in protein
synthesis (47). The remaining tRNA
Gly are functional in
both pathways as are a wide variety of tRNAs that have
been investigated in other organisms (19,20,25,26,30). This
implies that the tRNA-dependent transferases have devel-
oped their own interpretation of the genetic code to
achieve speciﬁcity, a question typically investigated with
substrates obtained by enzymatic acylation of tRNAs
(19,30,48). Since the aminoacyl-tRNA synthetases are
highly speciﬁc, the latter experimental approach is severely
limited by the substrates that can be analysed. Here we
have developed chemical acylation of RNA helices that
allowed for the ﬁrst time combining modiﬁcations in the
aminoacyl residue with any base substitution in the RNA
moiety of the substrate (Figure 2). Since the complex
organic syntheses were not feasible with radiolabelled
material, determination of FemXWv activity with these
substrates required to develop a novel assay in which the
radioisotope is introduced in the peptidoglycan precursor
rather than in the aminoacyl residue (Figure 3).
In a ﬁrst set of experiments, the contribution of the
aminoacyl residue to the FemXWv speciﬁcity was investi-
gated by comparing substrates obtained by misacylation
of an RNA helix that mimics the acceptor arm of
tRNA
Ala (helix
Ala). L-Ser and L-Ala were found to be
transferred from acyl donors containing an identical
helix with a relative eﬃciency of 7.0% (Figure 3). Since
a relative eﬃciency of 6.0% was previously observed for
comparison of the entire substrate (Ala-tRNA
Ala versus
Ser-tRNA
Ser) (30), this observation indicates that exclu-
sion of L-Ser from the FemXWv active site is in itself suf-
ﬁcient to quantitatively account for discrimination
between these two aminoacyl-tRNAs (Figure 8). In agree-
ment, transfer of L-Ala from helices mimicking the
acceptor arm of tRNA
Ala and tRNA
Ser occurred at rela-
tive eﬃciencies of 31% reﬂecting the moderate impact of
the A
73G (62%) and G
3A (45%) substitutions that were
also tested individually (Figure 6 and 8). Cys is likely to be
similarly excluded from the FemXWv active site although
this was not directly tested.
Several lines of evidence indicate that discrimination
against L-Ser, and presumably L-Cys, is due to steric hin-
drance. Helix
Ala charged with L-Ala and Gly were used
with relative eﬃciencies of 33% indicating that recogni-
tion of the methyl group of L-Ala has a marginal role in
the catalytic eﬃciency of FemXWv (Figure 3). In addition,
2-aminobutyrate was not transferred by FemXWv
(<0.01%) although D-Ala-helix
Ala was a substrate
(0.9%) (Figure 7). N-acetylation of L-Ala and extension
of the side chain from a methyl (L-Ala) to a CH2-CH2-
S-CH3 group (L-Met) both abolished FemXWv activity
(M. Lecerf, unpublished results). Together these results
indicate that the speciﬁcity of FemXWv involves steric hin-
drance rather than the recognition of the methyl group of
L-Ala. This mode of substrate recognition implies that
FemXWv can discriminate between L-Ala and all other
proteinogenic amino acids except Gly.
Since recognition of the L-Ala and Gly residues cannot
account for the speciﬁcity of FemXWv, we searched for
anti-determinants in the tRNA
Gly sequence (Figure 6).
Similar residual activities were observed for the transplan-
tation of the C
2-G
71 base pair of tRNA
Gly into the
Ala-Helix
Ala (1.8%) and the comparison of Ala-
tRNA
Ala and Gly-tRNA
Gly (2.6%) (Figure 8). Thus, the
C
2-G
71 base pair of tRNA
Gly acts as a major anti-deter-
minant that quantitatively accounts for the speciﬁcity of
FemXWv independently from the discrimination between
the Ala and Gly residues. The role of the recognition of
the RNA moiety of the substrate is also supported by the
inhibition of FemXWv by stable Ala-tRNA
Ala analogues
containing a mimetic of the acceptor stem of tRNA
Gly
since substitution of helix
Ala by helix
Gly in the RNA
moiety of the inhibitors led to a 48-fold increase in the
IC50s (Figure 5). Thus, the speciﬁcity of FemXWv for the
aminoacyl-tRNA donor substrate is based on excluding
aminoacyl residues larger than L-Ala from its active site
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Figure 7. Stereospeciﬁcity of FemXWv. The relative eﬃciency of FemXWv was estimated for the transfer of L-Ala, D-Ala and 2-amino-isobutyric acid
(Abu) from helix
Ala to UDP-MurNAc-[
14C]pentapeptide. A modiﬁed acetonitrile gradient (0–20%) followed by a step elution at 100% was used to
conﬁrm the absence of the transfer of Abu since the corresponding UDP-MurNAc-hexapeptide is expected to be hydrophobic and might have been
retained in the column under the classical conditions.
1598 Nucleic Acids Research, 2009, Vol. 37,No. 5and exploiting the ﬁrst divergent base pair in the acceptor
stems of tRNA
Ala and tRNA
Gly as an antideterminant to
prevent mis-incorporation of Gly (G
2-C
71 in tRNA
Ala
versus C
2-G
71 in tRNA
Gly). In agreement, modelling of
the donor substrate in the catalytic cavity of FemXWv
indicated that the enzyme can interact with the ﬁrst two
base pairs (1-72 and 2-71) of the acceptor stem of Ala-
tRNA
Ala, the single stranded ACCA extremity and the
aminoacyl residue (30). Eﬃcient binding of elongation
factor EF-Tu to aminoacyl-tRNAs also requires the cor-
rect combination of amino acid and tRNA body that have
independent and compensatory thermodynamic contribu-
tions to the overall aﬃnity thereby ensuring uniform bind-
ing to the 20 aminoacyl-tRNA types (49).
Aminoacyl-tRNA recognition by FemXWv and the
leucyl/phenyl-tRNA protein transferase (L/F-transferase)
involved in the control of protein degradation are very
diﬀerent although the two enzymes share a similar fold
in the absence of primary amino-acid sequence conserva-
tion (50,51). The catalytic cavity of the L/F-transferase
contains a hydrophobic pocket that accommodates the
side chain of Leu and Phe and eﬃciently excludes the
b-branched side chains of Ile and Val (48,50). The size
of the Ala and Pro side chains is not large enough to ﬁt
within the hydrophobic pocket whereas low activity was
detected with Met-tRNA
Met (50). Steric hindrance
accounts for the low activity observed with Trp-
tRNA
Trp (50). In contrast to FemXWv, biochemical
studies led to the conclusion that the L/F-transferase
recognizes the aminoacyl-tRNA substrates in a
sequence-independent manner (48,51). A double-stranded
acceptor stem is fully dispensable for the L/F-transferase
and replacement of G-C by weaker base pairs in the accep-
tor stem reduces the Km of the aminoacyl-tRNA substrate
(48). The opposite result was obtained for FemXWv
(Figure 6) since replacement of G
1-C
72 by unpaired
G
1 G
72 had a greater impact on FemXWv activity than a
double substitution that restored a Watson–Crick base
pairing (C
1-G
72) at this position (1.0% versus 6.5% resid-
ual activity, respectively).
Comparison of the L/F-transferase and FemXWv indi-
cates that the mode of recognition of the aminoacyl-tRNA
substrate is not conserved among enzymes that use this
type of activated substrate in non-translational processes.
Aminoacyl-tRNA recognition by component of the trans-
lation machinery is also diﬀerent, as exempliﬁed by the
analysis of the G
3 U
70 base pair, which is essential for
the activity of the alanyl-tRNA synthetase, but not of
FemXWv (45% relative eﬃciency; Figure 6). These obser-
vations suggest that Fem transferases are parasitic on the
translation machinery that provides a ubiquitous and per-
manent supply of amino acids activated in the form of
aminoacyl-tRNAs. Fem transferases may have therefore
evolved from a translation-independent pathway invol-
ving aminoacyl activation by adenylation, although the
enzymes may have lost the capacity to use a mono-nucleo-
tide as the substrate. The L/F-transferase binds phenyla-
lanyl-adeosine (rA-Phe) (45) and its analogue puromycine
(51). Transfer of Phe from rA-Phe to the N-terminal
Arg residue of a hexapeptide fragment of a casein has
been observed in co-crystals (51) and in solution at a
rate suﬃcient for detection of the product by mass
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Ala by
FemXWv (6.0% and 2.6%, respectively) (30). In this study, the main identity determinants of FemXWv were identiﬁed based on independently testing
the impact of substitutions of the aminoacyl residue and of nucleotides on FemXWv activity. Substitutions were chosen according to the diﬀerences
found in the distal portion of the acceptor arm of tRNA
Ala, tRNA
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Gly. The discrimination between L-Ala and L-Ser is the main factor
that prevents incorporation of L-Ser by FemXWv whereas the C
2-G
71 base pair in the acceptor arm of tRNA
Gly is the major anti-determinant that
prevents incorporation of Gly.
Nucleic Acids Research,2009, Vol.37, No. 5 1599spectrometry (51), although a larger portion of the
aminoacyl-tRNA substrate is required for eﬃcient
aminoacylation (48). Recognition of the acceptor stem
can be selectively advantageous, not only to provide spe-
ciﬁcity determinants (as shown for the 2–71 base pair in
this work), but also to ensure suﬃcient aﬃnity for the
aminoacyl-tRNA substrates in order to compete with
EF-Tu. The predominant recognition of the aminoacyl
moiety of the substrates by the L/F-transferase and
FemXWv as well as the diﬀerent modes of recognition of
the acceptor stems suggest multiple origins for these ami-
noacyl transferases that are unrelated to any tRNA-
interacting protein of the translation machinery.
FemXWv and the L/F-transferase should therefore be con-
sidered as enzymes that have developed their own inter-
pretation of the genetic code but did not participate in its
elaboration.
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